All Updates

All Updates

icon
Filter
Funding
GeneDx plans USD 150 million in public offering
Precision Medicine
Jan 27, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Jan 27, 2023

GeneDx plans USD 150 million in public offering

Funding

  • AI-powered genomic and clinical data intelligence company GeneDx (formerly Sema4) plans to raise USD 150 million via an underwritten public offering consisting of 428.6 million common shares priced at USD 0.35 per share. The offering includes a direct offering of 100 million shares to an institutional investor. The firm will also offer a 30-day option to underwriters to purchase an additional 49.3 million common shares. The offering is expected to close by January 31, 2023, subject to regulatory approval.

  • The sole book-running manager of the offering and placement agent of the direct offering is Jefferies, while GeneDx’s financial advisor is Cowen. 

  • The new funds will be used toward general corporate expenses including working capital, repayment of debts, and strategic investments.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.